Slides
Page 1
Consolidated Financial Results for the Three Months Ended June 30 , 2026 Securities Code : 7780 Menicon Co. , Ltd. August 7 , 2026 Copyright : Menicon Co. , Ltd. All rights reserved . Menicon
Page 2
Copyright: Menicon Co., Ltd. All rights reserved. Table of Contents 1 Consolidated Financial Results Summary for 1Q FY2026 Consolidated Financial Results Forecast for FY2026 Progress and Outlook for Milestone 2027 under the Medium-term Management Plan I II Ⅲ
Page 3
Copyright: Menicon Co., Ltd. All rights reserved. 2 I. Consolidated Financial Results Summary for 1Q FY2026
Page 4
Copyright: Menicon Co., Ltd. All rights reserved. Key Factors 3 +9.1% 1-DAY lens: Increased number of MELS Plan members due to an increased supply / Increased sales in Japan and overseas Ortho-K-related: Expanded sales regions outside China, impact of yen depreciation Net sales and profit both increased due to increased sales of 1-DAY lens. Vision Care Business JPY 32.3 bnNet sales Net sales JPY 30.2 bn YoY +7.1% JPY 17.5 bnGross profit JPY 3.4 bnOperating profit JPY 6.0 bnEBITDA Expand 1-DAY lens sales Effect of price increases Increased gross profit due to increased sales of 1-DAY lens Reviewed cost structure +7.0%YoY YoY +74.9%YoY +38.1%YoY Healthcare and Life Care Business Net sales JPY 2.1 bn YoY +6.5% Expanded Food business centered on the U.S. Maintained stable net sales in the Life Care business, etc.
Page 5
Copyright: Menicon Co., Ltd. All rights reserved. (JPY mn) FY2025 1Q FY2026 1Q YoY Net sales 30,251 32,376 +7.0% Cost of sales 14,144 14,811 +4.7% (Cost of sales ratio) 46.8% 45.7% (-1.1pt) Gross profit 16,107 17,565 +9.1% SGA 14,146 14,136 -0.1% (SGA ratio) 46.8% 43.7% (-3.1pt) Operating profit 1,961 3,429 +74.9% (Operating profit margin) 6.5% 10.6% (+4.1pt) EBITDA* 4,361 6,023 +38.1% (EBITDA margin) 14.4% 18.6% (+4.2pt) Ordinary profit 1,768 3,361 +90.1% Profit attributable to owners of parent 991 2,230 +124.9% Consolidated Financial Results Summary for FY2026 Prevailing exchange rates in FY2025 1Q EUR: JPY 165.1, USD: JPY 143.8, CNY: JPY 20.8 Prevailing exchange rates in FY2026 1Q EUR: JPY 186.1, USD: JPY 160.7, CNY: JPY 22.6 (Reference) Past figures are available in the following databook. https://www.menicon.co.jp/company/ir/databook.html* EBITDA is calculated from operating profit, depreciation, and amortization of goodwill. 4
Page 6
Copyright: Menicon Co., Ltd. All rights reserved. 5 (JPY mn) FY2025 1Q FY2026 1Q YoY Net sales 30,251 32,376 +7.0% Vision Care 28,217 30,211 +7.1% 1-DAY lens 8,124 9,237 +13.7% Japan 7,245 8,067 +11.4% Japan_MELS Plan 5,656 6,063 +7.2% Japan_Product sales 1,588 2,004 +26.2% Overseas 879 1,170 +33.1% Orthokeratology-related 3,279 3,766 +14.8% Other Contact lenses and Lens care products 16,813 17,206 +2.3% Healthcare and Life Care 2,034 2,165 +6.5% 1-DAY lens and Other Contact lenses and Lens care products 24,937 26,444 +6.0% MELS Plan 12,445 12,862 +3.4% Breakdown of Net Sales (Reference) Prevailing exchange rates in FY2025 1Q EUR: JPY 165.1, USD: JPY 143.8, CNY: JPY 20.8 Prevailing exchange rates in FY2026 1Q EUR: JPY 186.1, USD: JPY 160.7, CNY: JPY 22.6
Page 7
Copyright: Menicon Co., Ltd. All rights reserved. 0.8 1.1 1.5 2.0 5.6 6.0 FY2025 1Q FY2026 1Q (1) Japan_MELS Plan (2) Japan_Product sales (3) Overseas 8.1 9.2 (JPY bn) +13.7% Japan_MELS Plan (YoY: JPY +0.40 bn +7.2%) • Strengthened sales promotion due to increased supply. • Increased number of 1-DAY lens members. 1 Overseas (YoY: JPY +0.29 bn +33.1%) • Strengthened sales promotion due to increased supply. • Expanded 1-DAY lens sales. 3 Japan_Product sales (YoY: JPY +0.41 bn +26.2%) • Expanded business with new retail chains in Europe. • Started selling 1-DAY lens through major e-commerce sites in China. 2 6 1-DAY Lens Net Sales (Breakdown of Sales) Vision Care Sales increased due to increased supply of 1-DAY lens and strengthened sales promotion activities.
Page 8
Copyright: Menicon Co., Ltd. All rights reserved. 29.0% 29.4% ¥3,249 ¥3,301 ¥2,700 ¥2,900 ¥3,100 ¥3,300 27.5% 28.0% 28.5% 29.0% 29.5% 30.0% FY2025 4Q FY2026 1Q 1-DAY lens member composition ratio Average monthly fee * 7 Cumulative MELS Plan members 1.299 mn people Cumulative MELS Plan members 1.300 mn people * Average monthly fee = MELS Plan net sales ÷ Number of fiscal months ÷ Cumulative MELS Plan members Vision Care Change in MELS Plan Member Composition and Average Monthly Fee +0.4 pt 1-DAY lens member composition ratio * The 1-DAY lens composition ratio and average monthly fee rose due to an increase in the numbers of customers acquired and a higher MELS Plan membership rate.
Page 9
Copyright: Menicon Co., Ltd. All rights reserved. 8 1.9 2.0 0.8 1.1 0.48 0.55 FY2025 1Q FY2026 1Q (1) Ortho-K (Global)_Japan/Europe, etc. (1) Ortho-K (Global)_China (2) Lens care products (Asia) 3.2 3.7 (JPY bn) Ortho-K (Global) (YoY: JPY +0.34 bn +25.3%) • China: Increased due to strengthened relationships with customers and impact of yen depreciation. (JPY +0.26 bn) • Japan : Expanded the number of facilities. (JPY +0.02 bn) • Other Asia: Increased sales in Vietnam and other regions. 1 Lens care products (Asia) (YoY: JPY +0.14 bn +7.5%) • China: Impact of intensifying competition offset by yen depreciation. (JPY +0.11 bn) 2 +14.8% 1.3 1.6 Orthokeratology-related Net Sales (Breakdown of Sales) Vision Care Net sales increased due to growth in other Asian markets while economic stagnation and an intensifying competitive environment in China continue.
Page 10
Copyright: Menicon Co., Ltd. All rights reserved. 9 2.7 3.1 7.3 7.2 6.7 6.7 FY2025 1Q FY2026 1Q (1) MELS Plan (2) Contact lenses (3) Lens care products (other than Asia) 16.8 17.2 Net sales grew due to the increased sales of lens care products in Japan and overseas, in addition to increased sales of 1-MONTH lens in Europe. (JPY bn) MELS Plan (YoY: JPY +0.01 bn +0.2%) • Effect of price increases • Decreased non-1-DAY lens membership due to increased 1-DAY lens demand. 1 Lens care products (other than Asia) (YoY: JPY +0.42 bn +15.7%) • Decreased net sales of other companies’ products due to switching to the Company’s own 1-DAY lens at Group-operated stores. • Increased 1-MONTH lens sales in Europe. 3 Contact lenses (YoY: JPY -0.04 bn -0.6%) • Increased sales of high-unit-price products in Japan. • Increased sales in North America 2 +2.3% Other Contact Lenses and Lens Care Products (Breakdown of Net Sales) Vision Care
Page 11
Copyright: Menicon Co., Ltd. All rights reserved. 10 0.6 0.6 1.4 1.5 FY2025 1Q FY2026 1Q (1) Food business (2) Other 2.0 2.1 Net sales grew mainly due to increased sales in the Food business. (JPY bn) Food business (YoY: JPY +0.13 bn +9.5%) • Increased sales mainly in the U.S. 1 Other (YoY: JPY -0.00 bn -0.6%) • Secured stable net sales in the Life Care business, etc. 2 6.5% Healthcare and Life Care Net Sales Healthcare and Life Care
Page 12
Copyright: Menicon Co., Ltd. All rights reserved. Operating Profit and EBITDA 11 • Gross profit: JPY +1.45 bn (JPY 16.1 bn → JPY 17.5 bn) Expanded 1-DAY lens sales and effect of price increases • SGA: JPY -0.00 bn (JPY 14.1 bn → JPY 14.1 bn) Reviewed cost structure Operating profit (YoY: JPY +1.46 bn +74.9%) Operating profit margin (YoY: +4.1 pt) 1 • Depreciation: JPY +0.20 bn (JPY 2.24 bn → JPY 2.44 bn) Increased due to 1-DAY lens investments mainly at the Malaysia Plant. EBITDA (YoY: JPY +1.66 bn +38.1%) EBITDA margin (YoY: +4.2 pt) 2 (JPY bn) Profit increased as a result of growth in gross profit due to factors including increased sales of 1-DAY lens and a review of the cost structure. 1.9 3.4 4.3 6.06.5% 10.6% 14.4% 18.6% -40% -30% -20% -10% 0% 10% 20% FY2025 1Q FY2026 1Q (1) Operating profit (2) EBITDA (1) Operating profit margin (2) EBITDA margin
Page 13
Copyright: Menicon Co., Ltd. All rights reserved. 12 • Major SGA items 1.9 1.4 3.3 -0.10 0.03 0.06 0.01 FY2025 1Q operating profit Increase in gross profit Human capital investment Advertising/sales promotion (overseas) Advertising/sales promotion (Japan) Other SGA FY2026 1Q operating profit 1.0 1.5 2.0 2.5 3.0 3.5 SGA JPY+0.0 bn Decrease factors Increase factors 0.0 3.4++ + Items 1-DAY Lens Increased the number of MELS Plan 1-DAY lens members and increased sales in Japan and overseas. Orthokeratology- related Expanded the sales area for Ortho-K, impact of yen depreciation. Other Effect of price increases • Major components of zgross profit Operating profit increased as a result of growth in gross profit due to factors including increased 1-DAY lens sales, as well as a review of the cost structure. Analysis of Changes in Operating Profit (JPY bn) Items Human capital investment Wage increases in Japan and overseas, operational efficiency improvements Advertising/sales promotion (overseas) Review of sales promotion activities in China Advertising/sales promotion (Japan) The absence of initial costs associated with new product launches in the previous fiscal year Other Decrease in depreciation, etc.
Page 14
Copyright: Menicon Co., Ltd. All rights reserved. II. Consolidated Financial Results Forecast for FY2026 13
Page 15
Copyright: Menicon Co., Ltd. All rights reserved. 14 (JPY mn) FY2025 Results FY2026 1Q Results FY2026 Forecast Progress rate Net sales 125,605 32,376 133,000 24.3% Cost of sales 58,006 14,811 62,000 23.9% (Cost of sales ratio) 46.2% 45.7% 46.6% – Gross profit 67,599 17,565 71,000 24.7% SGA 57,363 14,136 60,000 23.6% (SGA ratio) 45.7% 43.7% 45.1% – Operating profit 10,236 3,429 11,000 31.2% (Operating profit margin) 8.1% 10.6% 8.3% – EBITDA 21,054 6,023 22,600 26.7% (EBITDA margin) 16.8% 18.6% 17.0% – Ordinary profit 11,021 3,361 10,500 32.0% Profit attributable to owners of parent 5,916 2,230 6,500 34.3% Results were strong and largely in line with expectations. Consolidated forecasts are unchanged from May. Prevailing exchange rates in FY2025 EUR: JPY 175.6, USD: JPY 151.1, CNY: JPY 20.9 Prevailing exchange rates in FY2026 1Q EUR: JPY 186.1, USD: JPY 160.7, CNY: JPY 22.6 Assumed prevailing exchange rates for FY2026 (forecast) EUR: JPY 180.0, USD: JPY 155.0, CNY: JPY 22.0 Financial Results Forecast and Progress for FY2026
Page 16
Copyright: Menicon Co., Ltd. All rights reserved. 15 (JPY mn) FY2025 Results FY2026 1Q Results FY2026 Forecast Progress rate Net sales 125,605 32,376 133,000 24.3% Vision Care 116,523 30,211 124,000 24.4% 1-DAY lens 33,809 9,237 37,700 24.5% Japan 30,054 8,067 32,200 25.1% Japan_MELS Plan 23,403 6,063 25,200 24.1% Japan_Product sales 6,651 2,004 7,000 28.6% Overseas 3,755 1,170 5,500 21.3% Orthokeratology-related 14,539 3,766 15,000 25.1% Other Contact lenses and Lens care products 68,174 17,206 71,300 24.1% Healthcare and Life Care 9,081 2,165 9,000 24.1% 1-DAY lens and Other Contact lenses and Lens care products 101,984 26,444 109,000 24.3% MELS Plan 50,687 12,862 51,700 24.9% Prevailing exchange rates in FY2025 EUR: JPY 175.6, USD: JPY 151.1, CNY: JPY 20.9 Prevailing exchange rates in FY2026 1Q EUR: JPY 186.1, USD: JPY 160.7, CNY: JPY 22.6 Assumed prevailing exchange rates for FY2026 (forecast) EUR: JPY 180.0, USD: JPY 155.0, CNY: JPY 22.0 (Reference) Breakdown of Net Sales and Progress Performance was strong and progressed largely in line with expectations.
Page 17
Copyright: Menicon Co., Ltd. All rights reserved. 16 10.2 3.4 -0.9 -0.8 -0.5 -0.2 11.2 FY2025 Operating profit Increase in gross profit Human capital investment Advertising/sales promotion (overseas) Advertising/sales promotion (Japan) Other SGA FY2026 Operating profit (forecast) 9.0 10.0 11.0 12.0 13.0 14.0 15.0 (1Q: -0.10) (1Q: +0.06)(1Q: +0.03) (1Q: +1.4) (1Q: +0.01) ↑ Expand 1-DAY lens sales ↓ Cost increase due to sales of products manufactured in Malaysia ↓ Cost increase for some raw materials ↓ Cost increase for logistics, etc. 11.0 Analysis of Changes in FY2025 Results and FY2026 Forecast (Operating Profit) Operating profit is expected to increase due to expanded sales of 1-DAY lens. Items Outlook for 2Q and beyond External factors affecting business performance Gross profit ↑ Japan: Increase in 1-DAY lens sales ↑ Overseas: Accelerate 1-DAY lens sales ↓ Cost increase due to sales of products manufactured in Malaysia · Foreign exchange fluctuations · Impact of the situation in the Middle East Operating profit ↑ Increase in gross profit ↓ Japan: Strengthen sales promotion toward the peak demand period ↓ Overseas: Strengthen sales promotion of 1-DAY lens (JPY bn) 0.0
Page 18
Copyright: Menicon Co., Ltd. All rights reserved. 17 Ⅲ. Progress and Outlook for Milestone 2027 under the Medium-term Management Plan
Page 19
Copyright: Menicon Co., Ltd. All rights reserved. Strengthening Production of 1-DAY Lens 18 The Company enhances production capacity primarily at the Malaysia Plant. Kakamigahara PlantMalaysia Plant Singapore Plant Products: 1DAY Menicon PremiO Sales area: Global (Sequentially) Products: 1DAY Menicon PremiO Sales area: Global Products: Magic Sales area: Global
Page 20
Copyright: Menicon Co., Ltd. All rights reserved. Strengthening Sales of 1-DAY Lens (Japan) 19 Strengthen sales activities with key customers · Promote retail product sales · Support customer acquisition strategies · Improve customer convenience through digital technologies Strengthen the sales foundation at Group- operated stores · Expand of the store network through new store openings and M&A · Implement of customer acquisition strategies · Promote of MELS Plan membership utilizing social media The Company establishes a foundation for increasing 1-DAY lens sales.
Page 21
Copyright: Menicon Co., Ltd. All rights reserved. Strengthening Sales of 1-DAY Lens (Overseas) 1-DAY lens sales increase in Europe, China, and Southeast Asia. 20 [Europe] Launch sales of 1-DAY lens to new accounts (Germany, Italy, and France) [China] Expand the 1-DAY lens lineup on major e-commerce websites [Southeast Asia] Launch sales of 1-DAY lens in Vietnam by strengthening collaboration with agencies and retail stores
Page 22
Copyright: Menicon Co., Ltd. All rights reserved. 28.4 30.9 33.8 37.7 46.0 47.5% 46.5% 46.2% 46.6% 52.5% 53.5% 53.8% 53.4% 20%20 FY2023 FY2024 FY2025 FY2026 FY2027 21 Profitability is expected to improve through expanded 1-DAY lens sales, mainly overseas. (Forecast) (Target) 1-DAY lens net sales (JPY bn) Toward Achieving Milestone 2027 Consolidated gross profit margin Consolidated cost of sales ratio
Page 23
Copyright: Menicon Co., Ltd. All rights reserved. 22 Reference Material
Page 24
Copyright: Menicon Co., Ltd. All rights reserved. Strengthen supply with a two-Plant system and establish a competitive advantage. Kakamigahara Plant Malaysia Plant 23 Achieves a comfortable wearing experience due to flexibility similar to hydrogel lenses, while maintaining high oxygen permeability. Superior wearing experience Product advantages (1) Product advantages (2) Product advantages Comparison of Young’s modulus* A smaller Young’s modulus figure indicates a softer material. *Young’s modulus is an indicator that expresses the “stiffness” of a material. Menicon’s unique contact lens case promotes hygienic use. Only 3 steps to wear the lenses! Open Pinch Attach The contact lens is stored in the case with its inside facing down. There is no need to touch the inside of the lens, enabling the user to easily to wear the lens without needing to check the lens orientation, which also makes the process more hygienic. 1-DAY Lens Growth Strategies Competitive Advantage (Production Capacity and Product Strength) contact lens smart zone
Page 25
Copyright: Menicon Co., Ltd. All rights reserved. 24 With production capacity expansion, growth is expected in the MELS Plan (increase in 1-DAY lens members) and overseas (sales expansion mainly in Europe and North America) 3.6 4.1 3.9 4.7 5.7 6.6 7.0 7.5 0.8 1.5 1.7 2.9 2.7 3.7 5.5 11.5 16.9 18.2 19.6 20.7 22.4 23.4 25.2 27.0 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025 FY2026 (Forecast) FY2027 (Target) MELS Plan Overseas Product sales in Japan 21.4 24.0 25.3 28.4 30.9 46.0 33.8 37.7 1-DAY Lens Net Sales Forecast (Breakdown of Net Sales) Vision Care (JPY bn)
Page 26
Copyright: Menicon Co., Ltd. All rights reserved. 25 Vision Care Orthokeratology-related Sales Forecast (Breakdown of Sales) Sales decline due to stagnant growth in the Chinese market, but growth is expected in other regions. (JPY bn) 2.7 6.8 10.0 9.4 9.1 8.3 15.0 16.0 2.8 4.0 4.8 5.5 5.7 6.1 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025 FY2026 (Forecast) FY2027 (Target) Ortho-K (Global) Lens care products (Asia) 5.6 10.9 14.8 15.0 14.8 15.0 16.0 14.5
Page 27
Copyright: Menicon Co., Ltd. All rights reserved. Major customers Medical institutions (ophthalmology) Expanding Our Business Domains Promote initiatives by positioning priority areas in Healthcare and Life Care. Aim to create a second core business while focusing on capital efficiency. Healthcare Healthcare and Life Care Life Care [Priority area] Peptide business [Priority area] Green infrastructure business Development of medical devices using self-assembling peptides. Promote medical applications by leveraging material design technologies cultivated through contact lens development. An approach that utilizes the diverse functions of nature for urban planning, disaster prevention, and environmental conservation. As a new domain of the environmental biotechnology business, contribute to reducing the burden of green space management. Major customers Home improvement stores, golf courses, commercial facilities, and e-commerce sales Products offered • Seers (ophthalmic material for maintaining visibility during glaucoma surgery) Launched in May 2026 • Verte (bioabsorbable bone regeneration material) Approval obtained in February 2026 Products offered • Naruoturf (low-maintenance zoysia grass) Launched in February 2025 26
Page 28
Copyright: Menicon Co., Ltd. All rights reserved. 27 3.7% 6.9% 10.9% 8.1% 8.3% 43.2% 47.1% 46.9% 46.2% 46.6% 53.1% 46.0% 42.1% 45.7% 45.1% 12% SGA ratio Cost of Sales Ratio / SGA Ratio / Operating Profit Margin Operating profit margin Cost of sales ratio
Page 29
Copyright: Menicon Co., Ltd. All rights reserved. Disclaimer and Cautions for Forward-Looking Statements 28 Disclaimer • This document was created by Menicon Co., Ltd. (hereinafter referred to as the “Company”) for the purpose of understanding the Company’s current situation in order to serve as a reference for all investors. • The contents of this document have been prepared based on the generally recognized economic and social conditions as of August 7, 2026 and certain assumptions that the Company deems reasonable. The contents are subject to change without notice due to factors such as changes in the business environment. • Investors should always rely upon their own judgment when making an investment. Cautions for forward-looking statements • The document and information provided in this presentation include so-called “forward-looking statements”. These statements are based on current expectations, forecasts and risks assumptions, and contain uncertainties that could lead to results that are substantially different from the statements. • These risks and uncertainties include general industry and market conditions, general domestic and international economic conditions such as interest rates and currency exchange fluctuations. • Even if there is new information or future events, the Company is not obligated to update or revise the "forward-looking statements" included in this presentation. Finance & IR Department, Menicon Co., Ltd. Contact information TEL: +81-52-935-1646 E-mail: menicon-ir@menicon.co.jp www.menicon.co.jp/company